title: Uterine adenofibroma and endometrial stromal sarcoma associated with tamoxifen therapy: MR findings.
abstract: Tamoxifen therapy may result in a variety of endometrial proliferative lesions, including adenofibroma and endometrial stromal sarcoma (ESS). This report describes the MR findings of adenofibroma and ESS associated with tamoxifen therapy. When MRI demonstrates a uterine mass appearing as a heterogeneous mass in the endometrium or myometrium, adenofibroma and ECC must be considered as rare, but possible, diagnoses.
authors.affiliation: Department of Radiology, National Center for Geriatrics and Gerontology, Japan. ckv37824@mopera.ne.jp
authors.forename: Kazumasa
authors.initials: K
authors.lastname: Hayasaka
authors.forename: Kazuo
authors.initials: K
authors.lastname: Morita
authors.forename: Tomoya
authors.initials: T
authors.lastname: Saitoh
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Tanaka
mesh_terms: D000232:Adenofibroma / Q000139:chemically induced* / Q000175:diagnosis; D000368:Aged; D000075202:Contraindications; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D018203:Sarcoma, Endometrial Stromal / Q000139:chemically induced* / Q000175:diagnosis; D013629:Tamoxifen / Q000008:administration & dosage; D014594:Uterine Neoplasms / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D013629:Tamoxifen